Prior studies report a greater incidence of second primary malignancy (SPM) among patients with myeloproliferative neoplasms, although the true risk in primary myelofibrosis (PMF) has not been elucidated. We utilized the Surveillance, Epidemiology, and End Results database to evaluate the risk of SPM in PMF patients and analyzed the effects of sociodemographic factors on the risk of SPM. Out of 5273 patients, 385 patients (7.30%) developed SPM. SPM occurred at SIR of 1.95 (95% CI 1.76-2.15) and AER of 149.01 per 10,000 population. A significantly higher incidence of melanoma (SIR 1.76, 95% CI 1.01-2.86), lymphoma (SIR 3.38, 95% CI 2.28-4.83), and leukemia (SIR 27.19, 95% CI 23.09-31.81) was observed. The risk was significantly higher in patients ≤60 years, males, chemotherapy recipients, within 5 years of PMF diagnosis, and for PMF diagnosed after 2009.

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2022.2123227DOI Listing

Publication Analysis

Top Keywords

second primary
8
primary malignancy
8
primary myelofibrosis
8
risk spm
8
patients
6
risk
5
spm
5
risk second
4
primary
4
malignancy patients
4

Similar Publications

Professional values and factors affecting these values in midwifery students.

Afr J Reprod Health

December 2024

Midwifery Department, Faculty and Health Sciences, Karabük University, Turkey.

This study investigated the professional values of midwifery students and the factors influencing these values. Conducted from January 6 to March 6, 2021, it involved 715 midwifery students who participated voluntarily. Data was collected using a Descriptive Data Sheet and the Professional Values of Midwives Scale.

View Article and Find Full Text PDF

Evaluation of Integrated Child Health Days as a Catch-Up Strategy for Immunization in Three Districts in Uganda.

Vaccines (Basel)

November 2024

U.S. Centers for Disease Control and Prevention, Global Immunization Division, Global Health Center, Atlanta, GA 30329, USA.

Uganda's Integrated Child Health Day (ICHD) initiative aims to improve children's access to vaccinations. Although widely used as a catch-up vaccination strategy, the effectiveness of the ICHD program in increasing immunization coverage, especially among vulnerable populations, has not been recently evaluated. This study assessed the reach and uptake of ICHD for immunizations in Uganda.

View Article and Find Full Text PDF

To address the difficulty in detecting workers' violation behaviors in electric power construction scenarios, this paper proposes an innovative method that integrates knowledge reasoning and progressive multi-level distillation techniques. First, standards, norms, and guidelines in the field of electric power construction are collected to build a comprehensive knowledge graph, aiming to provide accurate knowledge representation and normative analysis. Then, the knowledge graph is combined with the object-detection model in the form of triplets, where detected objects and their interactions are represented as subject-predicate-object relationship.

View Article and Find Full Text PDF

This work addresses the task allocation problem in spatial crowdsensing with altruistic participation, tackling challenges like declining engagement and user fatigue from task overload. Unlike typical models relying on financial incentives, this context requires alternative strategies to sustain participation. This paper presents a new solution, the Volunteer Task Allocation Engine (VTAE), to address these challenges.

View Article and Find Full Text PDF

COVID-19 became a global health crisis in early 2020, and the way out of the crisis was the rapid development of vaccines by Sinopharm, Pfizer, and Sputnik, among others, which played a crucial role in controlling the pandemic. Therefore, this study aims to investigate the long-term immune response by measuring the levels of anti-S1 IgG antibodies induced by homologous and heterologous vaccination regimens. We investigated the titer of the anti-S1 IgG antibody produced for the viral surface antigen 3, 6 months after the second dose, before the third dose, and 1, 3, and 6 months after the third dose.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!